Lucus Advisors’s Surmodics SRDX Stock Holding History

Lucus Advisors’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-19,710	Closed	-$430K	–	336
2015 Q3	$430K	Sell	19,710 -1,198	-6%	-$28.1K	0.24%	200
2015 Q2	$490K	Buy	+20,908	New	+$524K	0.23%	202

Other funds holding SRDX

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Lucus Advisors's SRDX Position: Q4 2015 in Review

Lucus Advisors sold out of Surmodics (SRDX) in Q4 2015, closing a stake of 19,710 shares — an estimated $430K sold.

Lucus Advisors first reported a position in SRDX in Q2 2015 and held it in 2 quarters. The position peaked at $490K in Q2 2015. 120 funds tracked by Wall St. Rank hold SRDX as of Q4 2015.

Lucus Advisors reported no remaining Surmodics position as of Q4 2015 after selling out during the quarter.
Lucus Advisors sold 19,710 Surmodics shares in Q4 2015, an estimated $430K.
Lucus Advisors first reported a position in Surmodics in Q2 2015 and held it in 2 quarters.
Lucus Advisors's Surmodics position peaked at $490K in Q2 2015.
120 funds tracked by Wall St. Rank held Surmodics as of Q4 2015.

Based on Lucus Advisors's 13F filing for Q4 2015, filed 11 Feb 2016.